Toronto-based Wittington Ventures has closed its third venture capital fund with $180 million CAD in commitments. The firm will invest the new capital in climate, commerce, consumer, healthcare, and food technology startups at Series A and B stages. Managing partner Jim Orlando announced the milestone on LinkedIn, marking a significant step for the seven-year-old investment platform.
A Larger Fund with Strategic Backing
The new fund is 50 percent larger than its $120 million CAD predecessor from 2022. Its limited partners include Wittington Investments, the Weston family holding company that controls Loblaw and Shoppers Drug Mart, along with undisclosed institutions. The close brings Wittington Ventures' total assets under management to $820 million CAD.
Investment Mandate and Differentiated Access
Wittington Ventures targets leading innovators across its core sectors at Series A and B. The firm plans to back approximately 15 companies from the new fund with an average investment of $10 million CAD each. Its main differentiator remains direct access to the commercial networks of Loblaw, Shoppers Drug Mart, Choice Properties, Holt Renfrew, and the broader Weston portfolio.
Seven Years of Platform Expansion
Wittington Ventures launched in 2019 under Jim Orlando, formerly of OMERS Ventures, with a single $100 million CAD fund focused on commerce and healthcare. The platform has since grown to a 15-person team managing $400 million CAD across three core venture funds. It now also operates a $100 million CAD early-stage deep tech strategy and $320 million CAD for growth-stage companies.
Leadership Continuity
The firm is led by managing partners Jim Orlando and Megh Gupta. Orlando oversees climate, commerce, and consumer investments after a career that included OMERS Ventures, where he backed companies such as Shopify and Wattpad. Gupta leads healthcare and artificial intelligence applications, bringing experience from Element AI and a previous role at OMERS Ventures.
Portfolio and Deployment Outlook
Wittington Ventures has not yet made any investments from the third fund. The firm has backed more than 25 companies to date, including Grey Matter Neurosciences, Odaia, Shakudo, ViewsML, and Gatik. Its growth strategy also includes a $100 million CAD carveout for Canadian food growers and producers.
What the Fund Means for Founders
Founders building Series A or B companies in consumer, healthcare, climate, commerce, or food technology are the clearest fit for this capital. The firm offers more than funding by connecting portfolio companies with a major Canadian retail and pharmacy network. This strategic access can open doors to commercial partnerships that generalist investors cannot easily replicate.
Market Significance in a Tight Environment
The fund's larger close arrives during a difficult fundraising climate for many venture firms, as Canadian and U.S. managers struggle to keep fund sizes flat. Wittington's ability to grow without a traditional LP roadshow highlights the resilience of family office capital in Canada. The additional firepower is structurally useful for Series A and B rounds, reducing dependence on multiple domestic funds to syndicate smaller checks.
Wittington Ventures intends to continue its established approach of patient capital and real-world operating support across all stages of company building. The firm expects its next seven years to resemble its first, with a continued focus on talented people tackling difficult problems in meaningful markets. With deeper ties to the Weston family operating network and a larger fund now in place, Wittington is positioned to remain a consistent and active domestic backer in its chosen sectors.